CVS Health Corporation $CVS Shares Sold by Pzena Investment Management LLC

Pzena Investment Management LLC cut its holdings in shares of CVS Health Corporation (NYSE:CVS) by 5.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 15,844,972 shares of the pharmacy operator’s stock after selling 901,881 shares during the quarter. CVS Health comprises 3.9% of Pzena Investment Management LLC’s portfolio, making the stock its 6th biggest holding. Pzena Investment Management LLC owned 1.25% of CVS Health worth $1,194,552,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Avion Wealth lifted its stake in CVS Health by 99.0% during the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 189 shares during the last quarter. Harbor Capital Advisors Inc. grew its position in CVS Health by 72.1% in the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 142 shares during the last quarter. Corundum Trust Company INC bought a new position in shares of CVS Health in the third quarter worth about $29,000. Front Row Advisors LLC grew its holdings in shares of CVS Health by 436.5% during the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 371 shares during the last quarter. Finally, Twin Peaks Wealth Advisors LLC acquired a new position in CVS Health during the 2nd quarter worth approximately $36,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

CVS Health stock opened at $77.81 on Thursday. The business has a fifty day moving average price of $78.65 and a 200-day moving average price of $76.57. The firm has a market capitalization of $98.99 billion, a P/E ratio of 56.38, a PEG ratio of 0.82 and a beta of 0.50. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. CVS Health Corporation has a one year low of $58.35 and a one year high of $85.15.

CVS Health (NYSE:CVS) last posted its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The business had revenue of $105.69 billion during the quarter, compared to analysts’ expectations of $103.67 billion. During the same period in the previous year, the business earned $1.19 earnings per share. The firm’s revenue was up 8.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, equities research analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.4%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s dividend payout ratio (DPR) is 192.75%.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the company. Wells Fargo & Company reduced their price objective on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a research report on Thursday, November 13th. Piper Sandler reiterated an “overweight” rating and set a $101.00 price objective (up previously from $99.00) on shares of CVS Health in a report on Wednesday, December 10th. Argus reduced their target price on CVS Health from $91.00 to $90.00 and set a “buy” rating for the company in a research note on Wednesday, January 28th. The Goldman Sachs Group upped their price target on CVS Health from $95.00 to $97.00 and gave the stock a “buy” rating in a research note on Thursday, February 12th. Finally, Evercore boosted their price objective on CVS Health from $85.00 to $95.00 and gave the company an “outperform” rating in a report on Thursday, October 30th. Nineteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $94.91.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.